purpose present results patients hepatocellular carcinoma hcc treated proton beam therapy experimental design reviewed NUMBER patients having NUMBER hccs treated november NUMBER july NUMBER proton beam therapy transarterial embolization percutaneous ethanol injection patients present series considered unsuitable surgery various reasons including hepatic dysfunction multiple tumors recurrence surgical resection concomitant illnesses median total dose proton irradiation NUMBER gy NUMBER fractions NUMBER days results overall survival rate NUMBER patients NUMBER NUMBER years local control rate NUMBER years NUMBER NUMBER tumors NUMBER patients degree impairment hepatic functions attributable coexisting liver cirrhosis number tumors liver significantly affected patient survival NUMBER patients having impaired hepatic functions solitary tumor survival rate NUMBER years NUMBER patients acute reactions treatments late sequelae treatments conclusions proton beam therapy patients hcc effective safe tolerable repeatable useful treatment mode cure palliation patients hcc irrespective tumor size tumor location liver insufficient feeding tumor arteries presence vascular invasion impaired hepatic functions coexisting intercurrent diseases